SHIMLA: In a drug alert issued for the month of August, samples of 59 medicines manufactured across India, including 20 from Himachal Pradesh, have failed to meet quality standards.
The substandard medicines are for a wide range of treatments, including those for gastric issues, ulcers, pneumonia, bacterial infections, diarrhea, throat pain, constipation, blood circulation problems, heart conditions, back pain, anticoagulation, mental illness, epilepsy, fever and blood pressure.
State Drug Controller Manish Kapoor confirmed the failure of these samples and announced that notices will be issued to cancel the licences of the pharmaceutical industries responsible. Kapoor also stated that the stock of these medicines will be recalled from the market immediately.
Also Read: https://thenewzradar.com/sukhu-cabinet-clears-50-bed-hospital-for-cm-wifes-constituency-nod-to-fill-over-100-posts-in-forest-health-depts/
In addition, the State Drug Control Department plans to conduct its own tests on the samples to ensure compliance with quality standards.
Out of the 20 substandard medicines from Himachal Pradesh, 14 were produced in Solan district, one in Una and five in Sirmaur.
List of Himachal-made samples & manufacturers
– Two gastric medication samples from Genosis Pharmaceutical Company in Moginand, Sirmaur.
– Ulcer medication Petomed, produced by Digit Vision Company in Kala Amb.
– Pneumonia medication Moxikaide CV, manufactured by Alexa Company in Baddi.
– Bacterial infection medication Amoxicillin, by MG Life Science in Sirmaur.
– Insulin enhancement medication Metfamin, produced by Scotodil Company in Jhadmajri.
– Diarrhoea medication Rixim, by Legion Healthcare in Parwanoo.
– Throat pain medication Faxofenadine, manufactured by Max Star Company in Malkumajra.
– Constipation medication Lactulose, produced by Athene Life Science in Kala Amb.
– Anticoagulant Heparin Sodium Injection, by Health Biotech in Sandoli.
– Antibiotic Cepodem Syrup, by Hetro Lab in Baddi.
– Pain medication Nimosulide, by Unispeed in Katha Baddi.
– Blood flow medication Adrenaline, by Elvis Health Care Company in Nalagarh.
– Back pain medication Diclofenac, by Universal Twin Lab in Gullarwala.
– Mental illness medication Clonazepam, by Digital Vision in Kala Amb.
– Epilepsy medication Phenytoin, by Health Biotech in Sandoli.
– Fever medication Paracetamol, by Bin Cure Pharma Company in Baddi.
– Blood pressure medication Telmisartan, by Swiss Garnier Company in Una.
The development has raised significant concerns about the quality of medicines being manufactured in the region. The pharmaceutical companies involved now face the possibility of having their licences revoked, which could severely impact their operations.
